Related Jobs
-
Director Medical Affairs (Gastrointestinal)
Job Type: Permanent
Salary: £ 80000.00 per annum
Location: England - Surrey -
Medical Liaison, Neuroscience
Job Type: Permanent
Salary: $CAD 120000.00 per annum
Location: Canada
GSK to sell cut price HIV/Aids drugs to Russia
15 Sep 2006
Medical Information
A deal has been agreed between GlaxoSmithKline (GSK) and the Russian government for HIV/Aids drugs to be sold at "discounted prices," the company announced today.
More than 90,000 treatment packs of the anti-retroviral treatments Combivir, Epivir and Ziagen will be supplied to Russia by the end of this year.
GSK already supplies antiretrovirals to sub-Saharan Africa, but this is the first federal purchase of this sort involving Russia, where the Economist estimates there are around a million people infected with HIV.
Andrew Witty, GSK's European pharmaceuticals president, said in a press statement: "Today's agreement will significantly increase access to HIV treatment in Russia.
"GSK has a long-standing commitment to improving access to its HIV medicines across the world and is delighted to continue this, by playing a full part in supporting the efforts of the Russian government. We applaud the Russian government's commitment to tackling the epidemic and look forward to further partnership."
By the end of this year the Russian government aims to be treating 15,000 HIV patients, according to Reuters, a figure that it looks to double by the end of next year.
The Economist further reports that the Russian HIV/Aids budget is this year in the region of £65 million, a figure it argues to be much smaller than that necessary to adequately address the problem.
© Adfero Ltd
